Terms: = Pancreatic cancer AND TG, Thyroglobulin AND Prognosis
15 results:
1. Prognostic significance of glucose-lipid metabolic index in pancreatic cancer patients with diabetes mellitus.
Wang H; Ruan S; Wu Z; Yan Q; Chen Y; Cui J; Zhang Z; Huang S; Hou B; Zhang C
Cancer Med; 2024 Mar; 13(6):e7108. PubMed ID: 38523554
[TBL] [Abstract] [Full Text] [Related]
2. Plasma lipid levels are associated with the CD8+ T-cell infiltration and prognosis of patients with pancreatic cancer.
Wu B; Shen W; Wang X; Wang J; Zhong Z; Zhou Z; Chen X
Cancer Med; 2023 Jul; 12(13):14138-14148. PubMed ID: 37184113
[TBL] [Abstract] [Full Text] [Related]
3. Effects of Serum Lipids on the Long-Term prognosis of Ampullary Adenocarcinoma Patients after Curative Pancreatoduodenectomy.
Li Z; Zhang X; Sun C; Fei H; Li Z; Zhao D
Curr Oncol; 2022 Nov; 29(11):9006-9017. PubMed ID: 36421359
[TBL] [Abstract] [Full Text] [Related]
4. [Changes of serum lipid profiles and the correlation analysis in clinic-pathological features of pancreatic cancer patients].
Yang J; Fan ZY; Li YZ; Liu SJ; Meng YF; Xu JW; Wang L; Zhan HX
Zhonghua Wai Ke Za Zhi; 2022 Jul; 60(7):680-687. PubMed ID: 35775261
[No Abstract] [Full Text] [Related]
5. Calreticulin promotes EMT in pancreatic cancer via mediating Ca
Sheng W; Wang G; Tang J; Shi X; Cao R; Sun J; Lin YH; Jia C; Chen C; Zhou J; Dong M
J Exp Clin Cancer Res; 2020 Oct; 39(1):209. PubMed ID: 33028359
[TBL] [Abstract] [Full Text] [Related]
6. Cholestatic syndrome as initial manifestation of pancreatic metastasis of papillary thyroid carcinoma: case report and review.
Tramontin MY; Faria PAS; Nascimento CMD; Barbosa CA; Barros MFRP; Barros ARG; Carvalho RC; Castro Neto AKP; Andrade FA; Corbo R; Vaisman F; Bulzico D
Arch Endocrinol Metab; 2020 Apr; 64(2):179-184. PubMed ID: 32236313
[TBL] [Abstract] [Full Text] [Related]
7. Is subtotal gastrectomy feasible for the treatment of gastric stump cancer located at the anastomotic site after distal gastrectomy for benign lesions?
Ma F; Li Y; Li W; Kang W; Liu H; Ma S; Wang B; Xie Y; Zhong Y; Chen Y; Xue L; Tian Y
World J Surg Oncol; 2020 Feb; 18(1):43. PubMed ID: 32106866
[TBL] [Abstract] [Full Text] [Related]
8. Long Noncoding RNA
Li Y; Zhang Z; Yang Y; Ma J
Genet Test Mol Biomarkers; 2020 Jan; 24(1):38-46. PubMed ID: 31940242
[No Abstract] [Full Text] [Related]
9. FBXW10 promotes hepatocarcinogenesis in male patients and mice.
Luo YD; Zhang J; Fang L; Zhu YY; You YM; Zhang CC; Zheng P; Zhang LD; Yin LY; Xia F; Bie P; Xie CM
Carcinogenesis; 2020 Jul; 41(5):689-698. PubMed ID: 31400758
[TBL] [Abstract] [Full Text] [Related]
10. Meta-analysis of radiofrequency ablation for treating the local recurrence of thyroid cancers.
Zhao Q; Tian G; Kong D; Jiang T
J Endocrinol Invest; 2016 Aug; 39(8):909-16. PubMed ID: 26980591
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic role of the LCS6 KRAS variant in locally advanced rectal cancer: results of the EXPERT-C trial.
Sclafani F; Chau I; Cunningham D; Peckitt C; Lampis A; Hahne JC; Braconi C; Tabernero J; Glimelius B; Cervantes A; Begum R; Gonzalez De Castro D; Hulkki Wilson S; Eltahir Z; Wotherspoon A; Tait D; Brown G; Oates J; Valeri N
Ann Oncol; 2015 Sep; 26(9):1936-1941. PubMed ID: 26162609
[TBL] [Abstract] [Full Text] [Related]
12. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3.
Liu C; Cheng H; Shi S; Cui X; Yang J; Chen L; Cen P; Cai X; Lu Y; Wu C; Yao W; Qin Y; Liu L; Long J; Xu J; Li M; Yu X
Curr Mol Med; 2013 May; 13(4):467-78. PubMed ID: 23305226
[TBL] [Abstract] [Full Text] [Related]
13. [Impact of different gastrectomy and reconstruction methods on prognosis and quality of life in proximal gastric cancer].
Wu H; He YL; Xu JB; Cai SR; Ma JP; Chen CQ; Zhang XH; Wang L; Zhan WH
Zhonghua Wai Ke Za Zhi; 2012 Oct; 50(10):875-8. PubMed ID: 23302454
[TBL] [Abstract] [Full Text] [Related]
14. The neuronal differentiation factor NeuroD1 downregulates the neuronal repellent factor Slit2 expression and promotes cell motility and tumor formation of neuroblastoma.
Huang P; Kishida S; Cao D; Murakami-Tonami Y; Mu P; Nakaguro M; Koide N; Takeuchi I; Onishi A; Kadomatsu K
Cancer Res; 2011 Apr; 71(8):2938-48. PubMed ID: 21349947
[TBL] [Abstract] [Full Text] [Related]
15. MDM2 promoter polymorphism and pancreatic cancer risk and prognosis.
Asomaning K; Reid AE; Zhou W; Heist RS; Zhai R; Su L; Kwak EL; Blaszkowsky L; Zhu AX; Ryan DP; Christiani DC; Liu G
Clin Cancer Res; 2008 Jun; 14(12):4010-5. PubMed ID: 18559624
[TBL] [Abstract] [Full Text] [Related]
